Mark Poritz
Chief Tech/Sci/R&D Officer at CO-DIAGNOSTICS, INC.
Profile
Mark Poritz is currently the Chief Scientific Officer at Co-Diagnostics, Inc. He was previously the Chief Scientific Officer at Idaho Molecular, Inc. He holds a doctorate degree from the University of California and an undergraduate degree from Harvard College.
Mark Poritz active positions
| Companies | Position | Start |
|---|---|---|
| CO-DIAGNOSTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2022 |
Former positions of Mark Poritz
| Companies | Position | End |
|---|---|---|
Idaho Molecular, Inc.
 Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The private company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Chief Tech/Sci/R&D Officer | - |
Training of Mark Poritz
| University of California | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CO-DIAGNOSTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Idaho Molecular, Inc.
Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The private company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Health Technology |
- Stock Market
- Insiders
- Mark Poritz